Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Join/Renew
ASA Community
ASA Home
Code of Conduct
Volunteer
Skip main navigation (Press Enter).
Toggle navigation
Search Options
Home
Home
About Us
Join
Executive Committee
Sub-Committees
-Mentoring Program Committee
-Funding Program Committee
-Next Generation Stewardship Committee
-Fellows Nomination Committee
-Membership Committee
-Scientific Working Group Proposal Committee
-Leadership-in-practice Committee
Overview
EC Meeting Minutes
History
BIOP Turns 40
Charter
Join
Related Links
Manual of Operations
Working Groups
Alzheimer's Disease
Cell & Gene Therapy
Centralized Statistical Monitoring and Quality Tolerance Limits
Estimands in Oncology
Nonclinical Biostatistics
Pediatric Drug Development
Real World Evidence Scientific Working Group
Re-Randomization
Safety Scientific Working Group
Software Engineering Working Group
Statistical Methods in Oncology
Biopharmaceutical Software Working Group - Retired Group
Events
ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
ASA Biopharmaceutical Section Nonclinical Biostatistics Conference
Upcoming ASA Webinars
Biopharmaceutical Event Calendar
General Calendar
Media Contents
Webinar Archive
Podcasts
BIOP Youtube Channel
Biopharmaceutical Report
Directory
Awards
Best Nonclinical Paper
ASA Fellow Members in the Biopharmaceutical Section
Student Paper Competition
Scholarship Award
Past Award Winners
Safety Scientific Working Group
Toggle navigation
Home
Who We Are
Workstreams
WS1 Interdisciplinary Safety Evalulation
WS2 Safety Monitoring Statistical Methodology
WS3 Integration of RWE and RCT for Safety Decision Making
Presentations
Publications
(to be updated)
Workstream 1: Interdisciplinary safety evaluation
+
Presentation at ISBS Conference (August, 2017)
Invited Session at Joint Statistical Meetings (July, 2017)
Sources of Safety Data and Statistical Strategies for Design and Analysis in Clinical Trials
Two Presentations at DIA Annual Meeting (June, 2017)
Sources of Safety Data and Statistical Strategies for Design and Analysis in Clinical Trials
Invited Session at DIA China Quantitative Sciences Forum (August, 2016)
Session/Panel at the BIOP Regulatory-Industry Statistics Workshop (September, 2016)
Topic-Contributed Session/Panel at Joint Statistical Meetings (August, 2016)
Invited Session at Trends and Innovations in Clinical Trial Statistics Conference (May, 2016)
Session/Panel at the BIOP Regulatory-Industry Statistics Workshop (September, 2015)
Assessing the cardiovascular risk of anti-diabetic therapies in patients with type 2 diabetes mellitus
, UNC-Chapel Hill Department of Biostatistics (September, 2015)
Invited Session/Panel at Joint Statistical Meetings (August, 2015)
Invited Session at ISBS Conference (June, 2015)
Invited Session/Panel at SCT Annual Conference (May, 2015)
Assessing the cardiovascular risk of anti-diabetic therapies in patients with type 2 diabetes mellitus
, Poster at PSI Annual Meeting (May, 2015)
Invited Session/Panel at SCT/QSPI Conference (December, 2014)
Session at Trends and Innovations in Clinical Trial Statistics Conference (April, 2014)
Poster at the DIA/FDA Statistics Forum (April, 2014)
Workstream 2: Safety statistical methodology
+
Presentation at ISBS Conference (August, 2017)
Invited Session at Joint Statistical Meetings (July, 2017)
Sources of Safety Data and Statistical Strategies for Design and Analysis in Clinical Trials
Two Presentations at DIA Annual Meeting (June, 2017)
Sources of Safety Data and Statistical Strategies for Design and Analysis in Clinical Trials
Invited Session at DIA China Quantitative Sciences Forum (August, 2016)
Session/Panel at the BIOP Regulatory-Industry Statistics Workshop (September, 2016)
Topic-Contributed Session/Panel at Joint Statistical Meetings (August, 2016)
Invited Session at Trends and Innovations in Clinical Trial Statistics Conference (May, 2016)
Session/Panel at the BIOP Regulatory-Industry Statistics Workshop (September, 2015)
Assessing the cardiovascular risk of anti-diabetic therapies in patients with type 2 diabetes mellitus
, UNC-Chapel Hill Department of Biostatistics (September, 2015)
Invited Session/Panel at Joint Statistical Meetings (August, 2015)
Invited Session at ISBS Conference (June, 2015)
Invited Session/Panel at SCT Annual Conference (May, 2015)
Assessing the cardiovascular risk of anti-diabetic therapies in patients with type 2 diabetes mellitus
, Poster at PSI Annual Meeting (May, 2015)
Invited Session/Panel at SCT/QSPI Conference (December, 2014)
Session at Trends and Innovations in Clinical Trial Statistics Conference (April, 2014)
Poster at the DIA/FDA Statistics Forum (April, 2014)
Workstream 3: Linking and bridging RWE & RCT for safety decision making
+
Tutorial: Likelihood-Based Methods for Continuous Safety Monitoring of Pharmaceutical Products, Deming Conference (December, 2017)
Quantitative Sciences for Safety Monitoring during Clinical Development, Webinar for the Biopharmaceutical Section of the American Statistical Association (October, 2017)
Likelihood Ratio Test on Safety Data
at DIA China Quantitative Science Forum (Aug 2017)
Analytical Framework : Safety Assessment Committee in Drug Development
at JSM (Aug 2017)
JSM Panel:
Quantitative Safety Monitoring: Regulatory Landscape, Statistical Methodology and Cross-Disciplinary Scientific Engagement
(August, 2017)
Biopharm Safety Monitoring Working Group: Bayesian and Graphics Approaches Based on Regulatory Guidance at Joint Statistical Meetings (August, 2017)
Enhancing Visual Analytics Approaches in Safety Monitoring
(Aug 2017)
Type-1 Error Control in Safety Signal Detection in Clinical Trial Data A Talk from the ASA Biopharm Safety Monitoring Working Group
(Aug 2017)
When to alert a Safety Assessment Committee –A Bayesian Approach with Example at JSM
(Aug 2017)
Biopharm Safety Monitoring Working Group: Bayesian and Graphics Approaches Based on Regulatory Guidance
— Regulatory Discussant (Aug 2017)
Update on progress of ASA Biopharm Safety Monitoring Working Group
at International Chinese Statistics Association Applied Statistics Symposium (June, 2017)
Tutorial: Quantitative Sciences for Safety Monitoring during Clinical Development. An ICSA One-day short course from the ASA Biopharm Safety Monitoring Working Group (June, 2017)
Visual Analytics in Safety Monitoring – Beyond the Usual Graphs and Available Tools
at Midwest Biopharmaceutical Statistics Workshop (May, 2017)
Global Regulatory Landscape for Safety Monitoring: A Quantitative Perspective on behalf of the ASA Biopharm Safety Monitoring Working Group
(April, 2017)
Tutorial: Quantitative Sciences for Safety Monitoring in Clinical Development. Half-day short course at 72nd Annual Deming Conference on Applied Statistics (December, 2016)
DIA All Hands Meeting:
Safety Monitoring During Clinical Development
(September, 2016)
DIA China:
ASA Biopharm's Safety Monitoring working group: Survey of statisticians, thought leaders and regulatory guidance
(August, 2016)
ASA Biopharm's Safety Monitoring working group: Survey of statisticians, thought leaders and regulatory guidance
at Joint Statistical Meetings (August, 2016)
Safety Monitoring in Clinical Development
at DIA Statistics All Hands Webinar (May, 2016)
Skip Navigation Links
Privacy Policy
Report a Problem
Copyright © 2011 ASA. All rights reserved.
Powered by Higher Logic
×
Community Tags
Add a tag
x
User Tags may not contain the following characters: @ # $ & :